This Innovative Alectinib Technique Work Even When You Sleep! !

Матеріал з HistoryPedia
Версія від 14:40, 16 червня 2017, створена Leek58pond (обговореннявнесок) (Створена сторінка: Aim:?The aim of this study was to determine the [http://www.selleckchem.com/screening/anti-cancer-compound-library.html Anticancer Compound Library] frequency a...)

(різн.) ← Попередня версія • Поточна версія (різн.) • Новіша версія → (різн.)
Перейти до: навігація, пошук

Aim:?The aim of this study was to determine the Anticancer Compound Library frequency and nature of citations of this retracted paper in order to ascertain the potential impact of retractions on the literature. Methods:?The number of times the retracted article was cited was determined using the cited reference function of Google Scholar. Citations were classified into two groups to indicate whether the retraction had been acknowledged (��retraction acknowledged�� or ��retraction not acknowledged��). Articles not acknowledging the retraction were further classified as ��specific citation of data�� or ��cited in passing��. The search was conducted on 6th August 2013 with no search restrictions imposed. Results:?A total of 73 citations were found with 23 of these occurring before the retraction of the article. Of citations occurring after the retraction the majority (48/50) were classified as ��retraction not acknowledged.�� Even more concerning is that 20 of these discussed specific outcomes from this publication. Conclusion:?Journals publish retraction notices to correct the scientific record, in this case due to falsified data. However this information is not always effectively communicated as evidenced by authors continuing to cite an article without acknowledging the retraction. Implementation of a standard approach to report retractions may limit misinterpretation of a field of research, thereby preventing inappropriate management of chronic disease conditions. REDDEL H1, Alectinib mouse ROBERTS B2, CROCKETT A3, THOONEN B4, LUCAS A5, THAMRIN C1, SMEELE I6, SCHERMER T4 1Woolcock Institute of Medical Research, University of Sydney, Glebe, NSW, 2Department of Chest Diseases, Canisius Wilhelmina Hospital, Nijmegen, Netherlands, 3School of Health Sciences, University of South Australia, Adelaide, 4Primary and Community Care, Radboud University Medical Centre, Nijmegen, Netherlands, Sitaxentan 5Diagnostiek voor U, Eindhoven, Netherlands, 6Dutch College of General Practitioners (NHG), Utrecht, Netherlands Introduction:?Diagnosis of COPD is often based on a single spirometry test. However, stability of diagnosis based on FEV1/FVC ratio has not previously been reported. Aim:?In subjects at risk of COPD, we investigated shifts in diagnostic category (i.e. shifts between obstructed and non-obstructed) after 1 year, and predictors of these shifts. Methods:?We used data from Caucasian respiratory symptomatic ex- or current smokers aged ��?40 who were referred to diagnostic spirometry services by Dutch GPs, and for whom two spirometry tests were available 12?��?2 months apart. Demographics, BMI, smoking status and medication use were recorded. Diagnosis of airway obstruction was based on post-bronchodilator (post-BD) FEV1/FVC?